Greenwood Genetic Center Selects Cartagenia BENCHlab NGS, CNV Solutions for Clinical Data Analysis
Boston, MA and Greenwood, SC, USA: 19 March 2013 - Cartagenia, the world leader in providing genetic labs and clinicians software-based workflow support for variant assessment, lab reporting, and integration of diagnostic knowledge-bases, announced today that it has signed a license agreement for its BENCHlab NGS and CNV solutions with South Carolina-based Greenwood Genetic Center, a non-profit institute that provides clinical genetic services and diagnostic laboratory testing.
Cartagenia's NGS product is tailored to support the adoption of Next Generation Sequencing technology in clinical practice and focuses on standardizing the data interpretation process. The NGS product was created to handle such data as gene panels, exomes and whole genomes and to automatically generate clinical reports specific to Greenwood's needs.
After developing the product and using it extensively in Europe, Greenwood is the first US customer to license the NGS product.
Next > FRX Polymers Receives Investment of the Year Award from Flanders Government
Previous > Green Biologics is awarded Grant Funding to advance the industrial application of Synthetic Biology